Calamos Advisors
RMD icon

Calamos Advisors’s ResMed RMD Stock Holding History

Calamos Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,400
Closed -$206K – 764
2020
Q1 		$206K Hold
1,400
– – ﹤0.01% 684
2019
Q4 		$217K Buy
+1,400
New +$202K ﹤0.01% 753
2015
Q2 		– Sell
-181,490
Closed -$13M – 716
2015
Q1 		$13M Buy
+181,490
New +$11.8M 0.08% 238

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Calamos Advisors's RMD Position: Q2 2020 in Review

Calamos Advisors sold out of ResMed (RMD) in Q2 2020, closing a stake of 1,400 shares — an estimated $206K sold.

Calamos Advisors first reported a position in RMD in Q1 2015 and held it in 3 quarters. The position peaked at $13M in Q1 2015. 582 funds tracked by Wall St. Rank hold RMD as of Q2 2020.

  • Calamos Advisors reported no remaining ResMed position as of Q2 2020 after selling out during the quarter.
  • Calamos Advisors sold 1,400 ResMed shares in Q2 2020, an estimated $206K.
  • Calamos Advisors first reported a position in ResMed in Q1 2015 and held it in 3 quarters.
  • Calamos Advisors's ResMed position peaked at $13M in Q1 2015.
  • 582 funds tracked by Wall St. Rank held ResMed as of Q2 2020.

Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.